Drug Profile
Research programme: fibrosis therapeutics - Redx Pharma
Alternative Names: ROCK2 inhibitor -RedX PharmaLatest Information Update: 13 Mar 2020
Price :
$50
*
At a glance
- Originator Redx Pharma
- Class Anti-inflammatories; Antifibrotics; Hepatoprotectants; Small molecules; Urologics
- Mechanism of Action Rho-associated kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Fibrosis